[{"id":"9efa0e6c-fd29-4464-ad6d-b66de82b97eb","acronym":"","url":"https://clinicaltrials.gov/study/NCT02347449","created_at":"2021-01-18T11:09:54.086Z","updated_at":"2024-07-02T16:36:39.656Z","phase":"","brief_title":"The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population","source_id_and_acronym":"NCT02347449","lead_sponsor":"Sunnybrook Health Sciences Centre","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" HER-2 positive • ER positive • ER negative + HER-2 positive • ER positive + HER-2 positive","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • ER positive • ER negative + HER-2 positive • ER positive + HER-2 positive"],"overall_status":"Completed","enrollment":" Enrollment 100","initiation":"Initiation: 10/01/2014","start_date":" 10/01/2014","primary_txt":" Primary completion: 09/30/2016","primary_completion_date":" 09/30/2016","study_txt":" Completion: 09/30/2016","study_completion_date":" 09/30/2016","last_update_posted":"2020-10-23"}]